NECTA Dangerous Ideas in Drug Development - Immunocore
Update: 2023-08-01
Description
This week we chat with a guest from Immunocore who specialise in soluble T-cell receptor technology. We'll be diving into their work with KIMMTRAK in uveal melanoma, as well as exciting upcoming studies with PRAME and PIWIL1 across multiple cancer types.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
